Landscape of HIV Implementation Research Funded by the National Institutes of Health: A Mapping Review of Project Abstracts.
Implementation research
Mapping review
Research funding
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
18
12
2019
medline:
4
11
2020
entrez:
18
12
2019
Statut:
ppublish
Résumé
In 2019, the requisite biomedical and behavioral interventions to eliminate new HIV infections exist. "Ending the HIV Epidemic" now becomes primarily a challenge of will and implementation. This review maps the extent to which implementation research (IR) has been integrated into HIV research by reviewing the recent funding portfolio of the NIH. We searched NIH RePORTER for HIV and IR-related research projects funded from January 2013 to March 2018. The 4629 unique studies identified were screened using machine learning and manual methods. 216 abstracts met the eligibility criteria of HIV and IR. Key study characteristics were then abstracted. NIH currently funds HIV studies that are either formally IR (n = 109) or preparatory for IR (n = 107). Few (13%) projects mentioned a guiding implementation model, theory, or framework, and only 56% of all studies explicitly mentioned measuring an implementation outcome. Considering the study aims along an IR continuum, 18 (8%) studies examined barriers and facilitators, 43 (20%) developed implementation strategies, 46 (21%) piloted strategies, 73 (34%) tested a single strategy, and 35 (16%) compared strategies. A higher proportion of formal IR projects involved established interventions (e.g., integrated services) compared to newer interventions (e.g., pre-exposure prophylaxis). Prioritizing HIV-related IR in NIH and other federal funding opportunity announcements and expanded training in implementation science could have a substantial impact on ending the HIV pandemic. This review serves as a baseline by which to compare funding patterns and the sophistication of IR in HIV research over time.
Identifiants
pubmed: 31845078
doi: 10.1007/s10461-019-02764-6
pii: 10.1007/s10461-019-02764-6
pmc: PMC7220870
mid: NIHMS1588167
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1903-1911Subventions
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIDA NIH HHS
ID : P30DA027828
Pays : United States
Organisme : NIDA NIH HHS
ID : K08 DA037825
Pays : United States
Organisme : NIDA NIH HHS
ID : P30 DA027828
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI117943
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : P30AI117943
Organisme : National Institute of Allergy and Infectious Diseases
ID : P30AI094189
Références
Implement Sci. 2013 Mar 15;8:32
pubmed: 23497520
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
Am J Prev Med. 2012 Sep;43(3):337-50
pubmed: 22898128
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
Annu Rev Public Health. 2017 Mar 20;38:1-22
pubmed: 28384085
Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
J Med Libr Assoc. 2016 Jan;104(1):76-8
pubmed: 26807058
Am J Public Health. 2013 Jun;103(6):e38-46
pubmed: 23597377
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Implement Sci. 2018 May 29;13(1):71
pubmed: 29843740
Psychiatry Res. 2020 Jan;283:112521
pubmed: 31473029
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733